<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02518438</url>
  </required_header>
  <id_info>
    <org_study_id>190</org_study_id>
    <nct_id>NCT02518438</nct_id>
  </id_info>
  <brief_title>The Analgesic Efficacy of Wound Infiltration With Tramadol</brief_title>
  <official_title>A Randomized Trial of the Analgesic Efficacy of Wound Infiltration With Tramadol After Cesarean Delivery Under General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeditepe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeditepe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This double-blind, randomized trial examined whether tramadol wound infiltration decreased
      postoperative pain following cesarean delivery under general anesthesia or reduced the need
      for analgesics in the immediate postoperative period. Patients in the tramadol group consumed
      significantly less morphine at all time intervals than those in the control group. The
      investigators suggest that the use of wound infiltration with tramadol may be a useful
      technique in patients who undergo cesarean section under general anesthesia to reduce
      postoperative pain, improve recovery, and facilitate early contact of mothers with their
      babies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome measure in this study was cumulative morphine consumption.</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>The measure of need for analgesics in the immediate postoperative period in this study was cumulative morphine consumption.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>the tramadol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A preprepared 20 ml solution (tramadol 2 mgkg-1 within a 0.9% saline solution) was subcutaneously infiltrated after closure of the uterine incision and the rectus fascia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A preprepared 20 ml solution (0,9% saline solution) was subcutaneously infiltrated after closure of the uterine incision and the rectus fascia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>A preprepared 20 ml solution was subcutaneously infiltrated after closure of the uterine incision and the rectus fascia.</description>
    <arm_group_label>the tramadol group</arm_group_label>
    <other_name>Placebo (0,9% saline solution)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparity

          -  Gestation age between 37-40 weeks

          -  CS under general anesthesia

        Exclusion Criteria:

          -  Pre-eclampsia

          -  Cardiovascular problems

          -  Allergy to any of the study medications

          -  Chronic preoperative pain

          -  Regular analgesic use
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yeditepe University Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>KozyatagÄ±</state>
        <zip>37452</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>August 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2015</study_first_posted>
  <last_update_submitted>August 4, 2015</last_update_submitted>
  <last_update_submitted_qc>August 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeditepe University Hospital</investigator_affiliation>
    <investigator_full_name>Murat Haliloglu</investigator_full_name>
    <investigator_title>Medical doctor</investigator_title>
  </responsible_party>
  <keyword>Tramadol</keyword>
  <keyword>Postoperative analgesia</keyword>
  <keyword>Infiltration</keyword>
  <keyword>Cesarean section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

